stoxline Quote Chart Rank Option Currency Glossary
  
Denali Capital Acquisition Corp. (DECA)
9.2  0.7 (8.24%)    04-26 16:00
Open: 8.745
High: 9.44
Volume: 45,663
  
Pre. Close: 8.5
Low: 8.64
Market Cap: 65(M)
Technical analysis
2024-04-26 4:41:21 PM
Short term     
Mid term     
Targets 6-month :  11.09 1-year :  12.96
Resists First :  9.5 Second :  11.09
Pivot price 8.32
Supports First :  8.26 Second :  7.5
MAs MA(5) :  8.47 MA(20) :  8.3
MA(100) :  7.53 MA(250) :  9.5
MACD MACD :  0.3 Signal :  0.3
%K %D K(14,3) :  55.4 D(3) :  41.5
RSI RSI(14): 61
52-week High :  14.1 Low :  4.05
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ DECA ] has closed above the upper band by 6.8%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 39% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.44 - 9.47 9.47 - 9.5
Low: 8.55 - 8.59 8.59 - 8.63
Close: 9.13 - 9.19 9.19 - 9.25
Company Description

Denali Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to complete a business combination with companies primarily operating in the technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York.

Headline News

Thu, 11 Apr 2024
Denali Capital Acquisition Corp. Announces Extension of Deadline to Complete Business Combination - Investing.com Nigeria

Wed, 10 Jan 2024
Denali shareholders approve SPAC merger with Longevity Biomedical (NASDAQ:DECA) - Seeking Alpha

Tue, 09 Jan 2024
Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day ... - Markets Insider

Thu, 26 Jan 2023
Longevity Biomedical, Inc. and Denali Capital Acquisition Corp. Announce Business Combination to Create Nasdaq ... - PR Newswire

Wed, 01 Jun 2022
DECA Stock Price and Chart — NASDAQ:DECA — TradingView - TradingView

Tue, 31 May 2022
Denali Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants ... - PR Newswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 5 (M)
Shares Float 5 (M)
Held by Insiders 15.1 (%)
Held by Institutions 57.7 (%)
Shares Short 6 (K)
Shares Short P.Month 3 (K)
Stock Financials
EPS 0.05
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -1.16
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -3 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 1 (M)
Stock Valuations
PE Ratio 153.33
PEG Ratio 0
Price to Book value -7.94
Price to Sales 0
Price to Cash Flow -73.43
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android